Shareholders Approve Reverse Stock Split to Maintain Nasdaq Listing
CRIS is trading near its 52-week low of $0.181 (9.9% above the low) on elevated volume (7.3× avg).
Summary
Curis Inc. shareholders approved a reverse stock split, empowering the Board to implement it to prevent delisting from Nasdaq.
Key Events · Corporate Governance and Compliance · CRIS
-
Reverse Stock Split Approved
Stockholders voted to approve amendments to the company's charter to effect a reverse stock split, with a ratio ranging from 1-for-5 to 1-for-25, at the Board's discretion.
-
Addresses Nasdaq Delisting Threat
This approval is a direct response to the Nasdaq delisting determination letter received on May 1, 2026, due to the common stock failing to meet the minimum bid price requirement.
-
Board Granted Discretion
The Board of Directors now has the authority to determine the exact reverse split ratio and implement the split to maintain the company's Nasdaq listing.
Analysis · CRIS · Life Sciences
Curis Inc. shareholders have approved a reverse stock split, a critical measure to regain compliance with Nasdaq's minimum bid price requirement and avoid delisting. This approval provides the Board with discretion to implement a split ratio between 1-for-5 and 1-for-25. The company has been facing significant financial challenges, including a "going concern" doubt and no revenue, making the preservation of its exchange listing vital for future capital access.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRIS was trading at $0.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8M. The 52-week trading range was $0.18 to $2.48. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.